STOCK TITAN

Visionary Holdings Stock Price, News & Analysis

GV Nasdaq

Welcome to our dedicated page for Visionary Holdings news (Ticker: GV), a resource for investors and traders seeking the latest updates and insights on Visionary Holdings stock.

Visionary Holdings Inc. (Nasdaq: GV) generates news at the intersection of education, health management, anti-aging medical aesthetics, and regenerative medicine. Company announcements describe an ongoing strategic transformation from a traditional education- and real estate-focused business toward a diversified platform centered on high-end medical aesthetics and big health technology, with AI-enabled education remaining as a supplementary division.

News coverage for GV includes updates on its fiscal year 2025 annual report, where the company outlined progress in its business restructuring and reported initial revenue contributions from emerging health-related businesses. Releases also detail Visionary Holdings' focus on health management initiatives, including gastrointestinal health management and early-stage commercialization efforts in Asia.

Another key stream of news relates to regenerative medicine and stem cell technology. Visionary Holdings has reported a Global Product and Technology Licensing Agreement with Jiangsu Yike Regenerative Medicine Co., Ltd., the creation of Visionary Yike Stemcell Technologies Inc. in Canada, and the launch of a stem cell-based anti-aging product line through its Visionary Health Technology Group Limited subsidiary. These items highlight the company’s emphasis on stem cell therapy, cellular rejuvenation, and premium anti-aging offerings in Asian markets.

Governance and compliance developments are also prominent in GV’s news. The company has announced board renewal, the formation of specialized committees, leadership changes, and auditor appointments, as well as a Nasdaq notification regarding a delayed Form 20-F filing and its plan to regain compliance. Additional releases describe Visionary Holdings’ controlling stake in a joint venture focused on Traditional Chinese Medicine health preservation.

Investors and observers reviewing GV news can expect updates on strategic partnerships, joint ventures, product launches in anti-aging and regenerative medicine, governance changes, and disclosures related to its education and health businesses.

Rhea-AI Summary

On May 28, 2024, Visionary Holdings announced its transformation into a high-innovation and high-growth company. With a focus on education, AI, and life sciences, Visionary has subsidiaries in Canada and partners in China. The company's strategy includes global mergers and acquisitions to integrate new technologies and expertise, targeting high-innovation sectors like biotechnology and sustainable development. Visionary aims to digitize real-world assets for improved liquidity and market value, collaborating with major digital asset trading platforms. The leadership's strong strategic planning and execution capabilities are pivotal in driving the company's growth. Visionary focuses on enhancing human life quality through advanced technology and education.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
80.5%
Tags
none
-
Rhea-AI Summary

Visionary Holdings (NASDAQ: GV), a private education provider utilizing AI and life sciences, has announced an innovative, high-value business model and diversified development strategy. The company, with subsidiaries in Canada and partners in China, aims to generate significant returns for investors across short, medium, and long-term horizons. The strategy focuses on niche market transformation to drive profitability and growth. Visionary Holdings is well-regarded for its global reach and cutting-edge technology implementation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.75%
Tags
none
-
Rhea-AI Summary

Visionary Holdings announces a 1-for-15 share consolidation to increase its per share trading price and maintain its Nasdaq listing. Effective from May 29, 2024, the consolidation will reduce the number of ordinary shares from 55,368,883 to approximately 3,691,259. Fractional shares will be rounded up to the nearest whole share. Post-consolidation trading will begin on May 29, 2024, under the same ticker, GV. This move aims to help the company regain compliance with Nasdaq Listing Rules.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.75%
Tags
none
Rhea-AI Summary

Visionary Holdings, traded on NASDAQ under the symbol GV, has announced its position as a leading global provider of STEM-AI education solutions for young people. With subsidiaries in Canada and market partners in China, the company emphasizes innovation as a driver of international competitiveness amid the technological revolution.

AI, with applications in autonomous driving, robotics, smart manufacturing, and healthcare, is pivotal in this transformation. Visionary boasts nearly 100 intellectual property rights in AI-related technologies and over 100 products sold in more than 30 countries.

The global market for intelligent robots surged from $8.1 billion in 2017 to $22.1 billion in 2021 and is projected to reach $67.6 billion by 2026. Visionary aims to expand its market reach to over 100 countries, enhancing its future performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.13%
Tags
AI
-
News
Rhea-AI Summary

Visionary Holdings (NASDAQ: GV) announced a cooperation agreement between its subsidiary Farvision Career Education Group and Canadian International Career College (CICC) to explore the Asian market.

Signed on May 9, 2024, the agreement aims to address Canada's labor shortage in the personal support worker (PSW) sector by attracting foreign workers.

CICC offers a range of courses, such as Personal Support Worker Certificate, and upon completion, assists students with work visas and job referrals. This initiative is expected to generate new revenue for Visionary Holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.98%
Tags
none
-
News
Rhea-AI Summary

On May 19, 2024, Visionary Holdings (NASDAQ: GV) signed a cooperation agreement with ABB-FG to digitize and securitize real-world assets (RWA) at their Toronto properties. The transformation will utilize advanced digital technology and blockchain to enhance property value and facilitate global trading on ATS. This initiative aims to reduce operational costs, improve user experience, and boost revenue. Additionally, Visionary plans to develop a digital technology complex featuring three new buildings, totaling 1.5 million sq ft. This project aims to establish a landmark for Toronto's digital economy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
none
Rhea-AI Summary

Visionary Holdings (NASDAQ: GV) and China's Red Sun Group have announced a collaboration to establish a life sciences conglomerate in Toronto. The new venture aims to lead in the nicotinamide (whitening) and anti-aging NMN (nicotinamide mononucleotide) industries, leveraging Red Sun's raw material base and technological platform. The project includes the development of a full industry chain from raw materials to functional foods, skincare, and medical products. The NMN market, valued at $5 billion in 2023, is projected to grow to $12.93 billion by 2031, driven by the aging population and increasing demand for anti-aging solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.93%
Tags
none
-
Rhea-AI Summary

Visionary Holdings has announced its collaboration with Canada's B. Braun Biochip Technology Group to establish Visionary Biotechnology Group in Toronto. This partnership aims to leverage world-class biochip technology, addressing substantial market gaps in Canada and China. B. Braun has invested nearly $150 million in biochip development over the last decade, cooperating with renowned medical institutions. The new factory in China, a $300 million investment, will begin production in March 2025, with an anticipated five-year output value of over $3 billion. Visionary's biochip products serve multiple fields, including medical testing, drug R&D, animal quarantine, and cold chain transport, highlighting their broad application and market potential.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.68%
Tags
none
-
News
Rhea-AI Summary

Visionary Holdings (NASDAQ: GV), a private education provider focused on AI and life sciences, announced the appointment of Zhong Chen as the new CFO, effective May 6, 2024. The decision follows the resignation of former CFO Katy Liu on February 9, 2024, which wasn't due to any disagreements with the company. Mr. Chen, who is also the CEO, brings extensive experience in multinational enterprise project development, operational management, and capital operations to his new role.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.68%
Tags
none
Rhea-AI Summary

Visionary Holdings (NASDAQ: GV), a leading private education provider specializing in AI and life science technology, celebrated its second anniversary of listing on May 8, 2024. The event highlighted the company's achievements and honored key contributors, including Ms. Zhang Xiaohua, who received the highest honor of the evening. Visionary has made notable progress over the past two years, focusing on innovation and sustainable development. The company remains committed to technological advancements and providing high-quality services. Looking forward, Visionary aims to continue its growth and contribute more to society through ongoing collaboration and innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.68%
Tags
none

FAQ

What is the current stock price of Visionary Holdings (GV)?

The current stock price of Visionary Holdings (GV) is $0.325 as of April 8, 2026.

What is the market cap of Visionary Holdings (GV)?

The market cap of Visionary Holdings (GV) is approximately 1.7M.